Keyphrases
Levodopa-induced Dyskinesia
25%
Parkinson
25%
GBA1
18%
Parkinson's Disease
17%
Xanthine
12%
Child Sleep
12%
Randomized Crossover Study
12%
Sleep Quality
12%
Glycemic Control
12%
Children with Type 1 Diabetes
12%
Immediate Release Tablets
12%
Sustained Release Pellets
12%
Oral Sustained Release
12%
Elixir
12%
Disease Duration
12%
Non-hospitalized
12%
Deep Immune Profiling
12%
Mild COVID-19
12%
COVID-19 Immunity
12%
Dopaminergic Pathway
12%
Long-read Sequencing
12%
Combinatorial Analysis
12%
Luxembourgish
12%
Cardiovascular History
12%
Major Risk Factors
12%
Homozygous Familial Hypercholesterolemia (HoFH)
12%
Prognostic Analysis
12%
Risk Variant
12%
Variant Severity
12%
Insulin Pump
9%
Period Prevalence
8%
Lack of Sleep
6%
Sleep Interruption
6%
Glucose Measurement
6%
Sensor-augmented Pump
6%
Hypoglycemia
6%
Glucose Targets
6%
5-Flucytosine
6%
Plasma Exposure
6%
Pathogenic Variants
6%
Parkinson's Disease with Mild Cognitive Impairment
6%
Systemic Analysis
6%
Hospitalized COVID-19 Patients
6%
Coordinated Response
6%
Immunoprotective Effect
6%
Serological Parameters
6%
Family History
6%
Protective Antibody Levels
6%
Severe COVID-19 Patients
6%
PCR Diagnosis
6%
TCR Repertoire
6%
RIKEN
6%
Expert Support
6%
Non-carriers
6%
Confidence Interval
5%
Blood Test
5%
Informed Consent Form
5%
Capillary Blood
5%
Medicine and Dentistry
Parkinson's Disease
44%
Gut Microbiome
12%
Infection
12%
microRNA
12%
Progressive Supranuclear Palsy
12%
Mild Cognitive Impairment
12%
Observational Study
12%
Severe Acute Respiratory Syndrome Coronavirus 2
12%
Cardiovascular System
12%
Insulin Pump
12%
COVID-19
12%
Comorbidity
12%
Metabolomics
12%
Quality of Sleep
12%
Arm
12%
Insulin Dependent Diabetes Mellitus
12%
Glycemic Control
12%
Quality of Life
9%
Prevalence
7%
Cardiovascular Disease
7%
Hypoglycemia
6%
Metabolic Regulation
6%
Diseases
6%
Prematurity
5%
Informed Consent
5%
Cerebrovascular Disease
5%
Psychological Well-Being
5%
Capillary Blood
5%
Neuroscience
Parkinson's Disease
100%
L-DOPA
37%
Dyskinesia
37%
Mild Cognitive Impairment
25%
Progressive Supranuclear Palsy
12%
MicroRNA
12%
Insulin Pump
12%
Comorbidity
12%
Quality of Sleep
12%
Crossover Study
12%
Hypoglycemia
9%